| Literature DB >> 26363542 |
Jeffrey A Norton1, Geoffrey Krampitz2, Robert T Jensen3.
Abstract
Early diagnosis of multiple endocrine neoplasia (MEN) syndromes is critical for optimal clinical outcomes; before the MEN syndromes can be diagnosed, they must be suspected. Genetic testing for germline alterations in both the MEN type 1 (MEN1) gene and RET proto-oncogene is crucial to identifying those at risk in affected kindreds and directing timely surveillance and surgical therapy to those at greatest risk of potentially life-threatening neoplasia. Pancreatic, thymic, and bronchial neuroendocrine tumors are the leading cause of death in patients with MEN1 and should be aggressively considered by at least biannual computed tomography imaging.Entities:
Keywords: Clinical management; Endocrine neoplasia; Genetics; Multiple endocrine neoplasia
Mesh:
Year: 2015 PMID: 26363542 PMCID: PMC4571281 DOI: 10.1016/j.soc.2015.06.008
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN: 1055-3207 Impact factor: 3.495